Literature DB >> 8004822

The effects of in vivo cyclosporin A administration on rat thymic dendritic cells.

J G Damoiseaux1, L J Beijleveld, P J van Breda Vriesman.   

Abstract

Cyclosporin A (CsA) induces a graft-versus-host-like disease (GVHD) in lethally irradiated Lewis rats reconstituted with syngeneic bone marrow. The role of the thymus in the generation of disease has been unequivocally established. It has been suggested that the CsA-induced disappearance of thymic dendritic cells (DC) is responsible for the generation of the autoaggressive cells. In this study we quantify the loss of DC upon in vivo CsA administration in normal and bone marrow-reconstituted rats using an isolation technique. The phenotype of the DC is determined using MoAbs recognizing antigens which are expressed on thymic medullary DC. Furthermore, the functional aspects are assessed by determining the antigen presentation capacity. Short-term CsA exposure clearly affects the number of DC isolated from the thymus in a concentration-dependent manner. However, in all instances a substantial number of DC can be isolated from CsA-treated animals. These isolated DC exhibit an identical phenotype and function as DC isolated from control animals. Therefore, the partial deficiency of DC can not be held as essential for loss of tolerance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004822      PMCID: PMC1534557          DOI: 10.1111/j.1365-2249.1994.tb06059.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts.

Authors:  D J Paterson; W A Jefferies; J R Green; M R Brandon; P Corthesy; M Puklavec; A F Williams
Journal:  Mol Immunol       Date:  1987-12       Impact factor: 4.407

2.  Identification of Ia glycoproteins in rat thymus and purification from rat spleen.

Authors:  W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

Review 3.  Xenogeneic transplantation. A review.

Authors:  H Auchincloss
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

4.  Kinetics of inducer/effector cell generation in the thymus in cyclosporine-induced autoimmunity.

Authors:  K W Wodzig; G D Majoor; P J van Breda Vriesman
Journal:  Transplant Proc       Date:  1993-10       Impact factor: 1.066

5.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

6.  Ontogeny of the rat thymus micro-environment: development of the interdigitating cell and macrophage populations.

Authors:  A M Duijvestijn; T Sminia; Y G Köhler; E M Janse; E C Hoefsmit
Journal:  Dev Comp Immunol       Date:  1984       Impact factor: 3.636

7.  Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus.

Authors:  T Fukumoto; W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1982-03       Impact factor: 5.532

8.  Accessory cell function of thoracic duct nonlymphoid cells, dendritic cells, and splenic adherent cells in the Brown-Norway rat.

Authors:  L Nagelkerken; M Henfling; P van Breda Vriesman
Journal:  Cell Immunol       Date:  1985-07       Impact factor: 4.868

9.  Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.

Authors:  A Glazier; P J Tutschka; E R Farmer; G W Santos
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

10.  Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.

Authors:  R Sorokin; H Kimura; K Schroder; D H Wilson; D B Wilson
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.